Abstract
Focal and segmental glomerulosclerosis (FSGS) is a common cause of Nephrotic Syndrome in adults. Its most typical course runs from NS to progressive loss of renal function and may recur in the graft after renal transplantation. Current evidence favors prolonged corticosteroid therapy (6 months or longer) to induce remission of proteinuria. Steroid-dependent and steroid-resistant patients may benefit from treatment with cyclosporine or cyclophosphamide. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are effective in reducing proteinuria and are recommended in all patients with FSGS, particularly those with nonnephrotic proteinuria. FSGS can be idiopathic or secondary to glomerular hyperfiltration and high intraglomerular capillary pressure or to viral or toxin-mediated damage. The characteristic lesion is a segmental solidification of the glomerular tuft.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Meyrier, A. (2004) Nephrotic focal segmental glomerulosclerosis in 2004: An update. Nephrol Dial Transplant 19, 2437–2444.
D’Agati, V. (1994) The many masks of focal segmental glomerulosclerosis. Kidney Int 46, 1223–1241.
Ahmad, H., Tejani, A. (2000) Predictive value of repeat renal biopsies in children with nephrotic syndrome Nephron 84, 342–346.
Haas, M., Meehan, SM., Karrison, TG., Spargo, BH. (1997) Changing etiologies of unexplained adult nephrotic syndromes: a comparison of renal biopsy findings from 1976–1979 and 1995–1997 Am J Kidney Dis 30, 621–631.
Kitiyakara, C., Eggers, P., Kopp, JB. (2004) Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States Am J Kidney disease 44, 815–825.
Rivera, F., Lopez-Gomez, JM., Perez-Garcia, R. (2004) Spanish Registry of Glomerulonephritis. Clinicopathologic correlations of renal pathology in Spain. Kidney Int 66, 898–904.
Weber, S., Gribouval, O., Esquivel, EL., Morinière, V., Tête, MJ., Legendre, C., Niaudet, P., Antignac, C. (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence Kidney Int 66, 571–579.
Winn M. (2003) Approach to the evaluation of heritable renal disease and update on familial focal segmental glomerulosclerosis Nephrol Dial Transplant 18, 4–20.
Dantal J., Bigot, E., Bogers, W. et al. (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330, 7–14.
Ruf, R., Lichtenberg, A., Karl, SM. (2004) Patients with mutations of podocin don´t respond to standard steroid treatment of nephrotic syndrome J Am Soc Nephrol 15, 722–732.
D’´Agati, VD. (2004) Pathological classification of focal segmental glomerulosclerosis: A working proposal Am J Kidney Disease 43, 368–382.
Chun, MG., Korbet, SM., Schwartz, MM., Lewis, EJ. (2004) Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis and response to therapy of histologic variants J Am Soc Nephrol 15, 2169–2177.
Quereda, C., Ballarin, J., Galeano, C., García Lopez, F., Praga, M. (2007) Immunosupresive therapy of primary focal sclerosing glomerulonephritis in the adult a systematic review Nefrologia 27, 249–260.
Velosa, JA., Holley, KE., Torres, VE., Offord, KP. (1983 Sep) Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis Mayo Clin Proc 58 (9), 568–77.
Stirling, CM., Mathieson, P., Boulton-Jones, JM., Feehally, J., Jayne, D., Murray, HM., Adu, D. (2005) Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units QJM 98(6), 443–9.
Troyanov, S., Wall, CA., Miller, JA., Scholey, JW., Cattran, DC. Toronto Glomerulonephritis Registry Group (2005) Focal and segmental glomerulosclerosis: definition and relevance of a partial remission J Am soc nephrol 16, 1061–1068.
Pardon, A., Audard, V., Caillard, S., Molin B., Desvaux, D., Bentaarit, B., Remy, P., Sahali, D., Roudot-Thoraval, F., Lang, P., Grimbert, P. (2006) Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients Nephol Dial Transplant 21, 1053–1059.
Burgess, E. (1999) Management of focal and segmental glomerulosclerosis: evidence based recommendations Kidney Int 55 (S70), S26–S32.
Praga, M., Hernandez, E., Montoyo, C., Andres, A., Ruilope, LM., Rodicio, JL. (1992) Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria Am J Kidney Dis. 20, 240–248.
Delucchi, A., Cano, F., Rodriguez, E., Wolf, E., Gonzalez, X., Cumsille, MA. (2000) Enalapril and prednisone in children with nephrotic-range proteinuria Pediatr Nephrol 14, 1088–1091.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ballarín, J.A., Cabrera, C., Quereda, C., Díaz, M. (2008). Focal and Segmental Glomerulosclerosis. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_91
Download citation
DOI: https://doi.org/10.1007/978-1-60327-285-8_91
Publisher Name: Humana Press
Print ISBN: 978-1-60327-427-2
Online ISBN: 978-1-60327-285-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)